Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carnosine for Peripheral Arterial Disease
NCT04870229Phase 2Completed
- Sponsor
- University of Louisville
- Start
- May 2016
- Primary completion
- Jul 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carnosine in Peripheral Arterial Disease (PAD), sponsored by University of Louisville. Started May 2016; status: completed.
02
Drugs
carnosine
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT04870229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04870229.